HTD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 80.64 EUR -1.9%

Market Cap: €5.5B

C	Corcept Therapeutics Inc SWB:HTD	US
A	Ardelyx Inc F:41X	US
A	Agnico Eagle Mines Ltd XMUN:AE9	CA
L	Lockheed Martin Corp XMUN:LOM	US
S	Societe Generale SA F:SGE1	FR
W	WEX Inc F:WL9	US
U	UniCredit SpA XBER:CRIN	IT

Profitability Summary

Corcept Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Low Operating Margin

Sustainable 3Y Average Operating Margin

15%

Declining Operating Margin

23% > 1%

Low Net Margin

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

22% > 7%

Exceptional Free Cash Flow Margin

13%

Strong 3Y Average Free Cash Flow Margin

23%

Declining Free Cash Flow Margin

31% > 13%

Low ROE

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

31%

Declining ROIC

63% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.